White P F, Stanley T H, Apfelbaum J L, Grasela T H, Hug C C, McLeskey C H, Nahrwold M L, Roizen M F, Thisted R A, Walawander C A
Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, Dallas 75235-8894.
Anesth Analg. 1993 Oct;77(4 Suppl):S15-20.
During propofol-nitrous oxide (N2O) anesthesia, volatile anesthetics are frequently administered to treat signs of inadequate anesthesia and to decrease the possibility of intraoperative awareness. Because the clinical effects of this combination have not been examined rigorously, we used data from the 1989-90 Phase IV clinical trial with propofol to evaluate recovery from propofol-N2O anesthesia with and without supplementation with isoflurane. In this study involving 15,806 patients at 1722 institutions, propofol was administered for induction and maintenance of anesthesia with N2O for procedures lasting less than 60 min. At the discretion of the anesthesiologist, volatile anesthetics were administered as needed during maintenance of anesthesia (the incidence of use of inhaled anesthetics was 14.7% for isoflurane, 2.2% for enflurane, and 0.2% for halothane). Other intraoperative medications included opioid analgesics, muscle relaxants, and anticholinergic drugs. The present study concerns the subset of 7796 patients given propofol-N2O maintenance anesthesia (intermittent bolus or continuous infusion) with or without isoflurane supplementation for procedures lasting less than 60 min. Isoflurane was used more frequently for procedures lasting 30-60 min than for those less than 30 min. Nevertheless, the maintenance dose of propofol was significantly (P < 0.05) less with isoflurane (178 vs 235 mg). Adjunctive use of isoflurane prolonged the time to awakening and to becoming oriented, but discharge times were similar for the two groups. The incidence of postoperative nausea, vomiting, recall, and excitement did not differ between the two groups. We conclude that the addition of isoflurane to a propofol-N2O anesthetic does not alter recovery from anesthesia.
在丙泊酚-氧化亚氮(N₂O)麻醉期间,常给予挥发性麻醉药以处理麻醉不足的体征,并降低术中知晓的可能性。由于这种联合用药的临床效果尚未得到严格研究,我们使用了1989 - 1990年丙泊酚IV期临床试验的数据,来评估在补充异氟烷和未补充异氟烷的情况下,从丙泊酚-N₂O麻醉中恢复的情况。在这项涉及1722家机构的15806例患者的研究中,丙泊酚用于诱导和维持麻醉,同时使用N₂O进行持续时间少于60分钟的手术。根据麻醉医生的判断,在麻醉维持期间按需给予挥发性麻醉药(吸入麻醉药的使用发生率分别为:异氟烷14.7%、安氟醚2.2%、氟烷0.2%)。其他术中用药包括阿片类镇痛药、肌肉松弛剂和抗胆碱能药物。本研究关注的是7796例接受丙泊酚-N₂O维持麻醉(间歇性推注或持续输注)且手术持续时间少于60分钟的患者亚组,这些患者补充或未补充异氟烷。异氟烷在持续时间为30 - 60分钟的手术中比在持续时间少于30分钟的手术中使用更频繁。然而,使用异氟烷时丙泊酚的维持剂量显著更低(P < 0.05)(分别为178毫克和235毫克)。辅助使用异氟烷延长了苏醒时间和定向时间,但两组的出院时间相似。两组术后恶心、呕吐、回忆和兴奋的发生率没有差异。我们得出结论,在丙泊酚-N₂O麻醉中添加异氟烷不会改变麻醉恢复情况。